No. 7 / 2025 Resolutions from Zealand Pharma's Annual General Meeting 2025 Copenhagen, Denmark, March 27, 2025 - Zealand ...

No. 6 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, March 25, 2025 – ...

Detailed price information for Zealand Pharma A/S (ZLDPF) from The Globe and Mail including charting and trades.

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Vicarious Surgical. The company’s shares closed last Monday at $9.63. According to TipRanks.com, Zimmerman is ...

Zealand Pharma (ZLDPF) announced that the last participant has been enrolled and randomized to active treatment or placebo in ZUPREME-1, a global Phase 2b trial in people with obesity or ...

Zealand Pharma A/S (OTCMKTS:ZLDPF – Free Report) – Equities research analysts at William Blair lowered their FY2025 earnings per share estimates for shares of Zealand Pharma A/S in a research ...

(Repeats Feb 16 story with no changes to text) By Medha Singh and Manas Mishra (Reuters) - U.S.-based Eli Lilly (NYSE:LLY) and... By Medha Singh and Manas Mishra (Reuters) - U.S.-based Eli Lilly ...

Overview: Zealand Pharma A/S is a biotechnology company focused on discovering, developing, and commercializing peptide-based medicines in Denmark and the United States, with a market ...

Shares of weight loss drug developers gained on Wednesday after Roche (OTCQX:RHHBF) announced a multi-billion-dollar deal with Danish biotech Zealand Pharma (OTCPK:ZLDPF) to jointly develop an ...